Evonik opens new facility for pharmaceutical lipids in Germany

New GMP facility for clinical and small-scale commercial pharmaceutical lipids

Pharmapack 2023 a pivotal moment for sustainability in drug delivery and packaging

Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event

Zydus receives final approval from the USFDA for Pitavastatin Tablets

All AIIMS can transform into institutes of global excellence: Dr. Mandaviya

He urged the dignitaries to collaboratively work on the identified domains of improvement and make detailed reports on them

CellOrigin Biotech collaborates with Qilu Pharma to develop CAR-iMAC Cell Therapy

Zydus receives final approval from USFDA for Cariprazine Capsules

Cariprazine is an atypical antipsychotic indicated for the treatment of schizophrenia and acute treatment of manic or mixed episodes associated with bipolar I disorder

WuXi STA opens a new sterile lipid nanoparticle formulation facility

This new facility integrates multi-channel chip, micro-mixer system, and complex preparation system into a multi-channel micro-mixer core LNP manufacturing platform

Unichem receives ANDA approval for quetiapine extended-release tablets

Quetiapine Extended-Release Tablets are indicated for the treatment of Schizophrenia, Bipolar disorder and adjunctive treatment of Major Depressive Disorder (MDD)

Roche's Elecsys Amyloid Plasma Panel granted FDA breakthrough device designation to enable a timely diagnosis of Alzheimer’s disease

The Elecsys Amyloid Plasma Panel has the potential to ensure better identification of patients that require further confirmatory testing, supporting a more timely and accessible diagnosis.

Silo Pharma expands license agreement and patent portfolio

Silo enters into commercial evaluation license agreement for next generation liposomes